by admin | May 13, 2023 | News & Opinions
STING-seq provides roadmap to identify variants and genes, enabling deeper understanding of the noncoding genome and targets for therapies By NYU News A major challenge in human genetics is understanding which parts of the genome drive specific traits or contribute to...
by admin | May 12, 2023 | News & Opinions
by Justin Jackson – Phys.org Researchers at Sana Biotechnology, Inc., in California, have made a significant breakthrough in realizing the promise of stem cell therapy: stem cells that do not trigger an immune response from an immunologically incompatible donor....
by admin | May 10, 2023 | News & Opinions
By Longeveron MIAMI, May 09, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced new...
by admin | May 9, 2023 | News & Opinions
by Innovation Quarter Some things are worth traveling for. We drive the extra hour to one-of-a-kind restaurants, we cross state lines for best-in-class specialists and we travel days to experience unrivaled natural wonders. One day, there will be products that we have...
by admin | May 6, 2023 | News & Opinions
Aubrey de Grey explains why the time is right to be extremely ambitious and audacious when it comes to longevity research. By Eleanor Garth – Longevity.Technology August will see the second annual Longevity Summit take place in Dublin. Packed with keynote...
